Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

This Is Why SoFi Stock Might Rebound

By Chris Lau, InvestorPlace Contributor

A 2022 guidance cut compelled investors to sell shares earlier this month creating a wide discount to SoFi's stock price.

What China’s Lockdown and Higher Prices Mean for Nio Stock

By Chris Lau, InvestorPlace Contributor

Despite pandemic disruptions, NIO stock still enjoys strong long-term prospects -- fueled by the firm's global expansion and strong demand.

Rivian Looks Like It’s Entering Bargain Territory

By Chris Lau, InvestorPlace Contributor

RIVN stock may find support at the $40 level, setting up a breakout after electric vehicle investors accumulate shares at these levels.

7 Cheap Stocks to Buy Before the Next Breakout

By Chris Lau, InvestorPlace Contributor

Beaten-down equities have the best chance of breaking out as investors realize their growth potential. Here are some cheap stocks to buy now.

Why the Immense Selling Pressure on the SPY ETF Must End

By Chris Lau, InvestorPlace Contributor

News for key technology stocks Microsoft, Tesla, and Amazon pulled SPY stock lower for now, creating a good buy from here.

Load More